My late gains in celgene were poetic justice or karma in a way since I had been invested (gambling) in enmd (Entremed) from which celgene got the thalidomide derived basis for celgene’s blockbuster drug that established celgene and is still contributing the lions share (to BMY now.)
FWIW enmd is now CASI and has different management and strategy, acquiring existing cancer drugs to get them approved and marketed in China. Looks like most of the company operates in China. I did recently notice that their cost of sales is just about equal to the revenues from sales, which raises some questions or maybe the costs are high because these are the first product sales of their first approved drug.
You had every reason to not pursue celgene at the time. No regrets
News 
Market Data 
Discover 
